MedPath

A clinical trial to study the effect of R-TPR-020 in patients undergoing treatment for infertility.

Phase 3
Completed
Conditions
Health Condition 1: null- Infertile females undergoing for controlled ovarian hyperstimulation (COH).or patients undergoing treatment for Polycystic ovarian syndrome (PCOS)
Registration Number
CTRI/2009/091/000888
Lead Sponsor
Reliance Life Sciences Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
45
Inclusion Criteria

1.Female subjects age 18 years to 40 years (both inclusive) at the time of screening.

2.Infertile females of couples undergoing for controlled ovarian hyperstimulation (COH) or patients undergoing treatment for Polycystic ovarian syndrome (PCOS).

3.Patients with BMI between 18-29 kg/m2 (both inclusive) at the time of screening.

Exclusion Criteria

1.History of clinically significant endocrine related abnormality

2.History / presence of undiagnosed vaginal bleeding

3.History of primary ovarian failure

4.Any ovarian and/or abdominal abnormality interfering with ultrasound examination;

5.History of clinically significant diseases, e.g. epilepsy, diabetes, cardiovascular, gastro-intestinal, hepatic, renal, pulmonary, or abdominal disease

6.Use of hormonal preparations within one month prior to the start of FSH with the exception of thyroid medication.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath